HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Min Liu Selected Research

Esophageal Squamous Cell Carcinoma

9/2020OP16 induces deadly autophagy and apoptosis of cells by inhibiting Akt in esophageal squamous cell carcinoma.
11/2018FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.
1/2017OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
1/2016Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Min Liu Research Topics

Disease

119Neoplasms (Cancer)
03/2024 - 10/2008
39Stomach Neoplasms (Stomach Cancer)
11/2023 - 11/2013
7Esophageal Neoplasms (Esophageal Cancer)
03/2018 - 07/2013
6Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2011
5Neoplasm Metastasis (Metastasis)
01/2023 - 01/2016
5Carcinogenesis
01/2023 - 06/2013
4Inflammation (Inflammations)
10/2023 - 12/2016
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2020
4Breast Neoplasms (Breast Cancer)
01/2023 - 10/2011
4Esophageal Squamous Cell Carcinoma
09/2020 - 01/2016
3Leukemia
05/2023 - 01/2021
3Infections
03/2023 - 06/2013
3Melanoma (Melanoma, Malignant)
01/2023 - 03/2021
3Carcinoma (Carcinomatosis)
01/2021 - 11/2016
2Lymphoma (Lymphomas)
05/2023 - 01/2023
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2023 - 09/2020
2Fibrosis (Cirrhosis)
10/2022 - 07/2019
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2021 - 11/2014
2Acute Promyelocytic Leukemia
01/2021 - 01/2021
2Infarction (Infarctions)
07/2019 - 05/2014
2Neuroblastoma
05/2016 - 10/2011
2Pulmonary Arterial Hypertension
03/2012 - 12/2010
1Genomic Instability
09/2023

Drug/Important Bio-Agent (IBA)

28Lysine (L-Lysine)FDA Link
01/2024 - 06/2013
14Histones (Histone)IBA
11/2023 - 06/2013
13Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2017
13DiterpenesIBA
02/2022 - 07/2013
13pyrimidineIBA
02/2021 - 11/2013
10Kaurane DiterpenesIBA
02/2022 - 07/2013
9oridoninIBA
01/2023 - 11/2016
7Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2013
7Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 04/2013
6EnzymesIBA
01/2023 - 06/2013
5Immune Checkpoint InhibitorsIBA
03/2024 - 07/2022
5Cullin Proteins (Cullins)IBA
11/2023 - 01/2021
5Antineoplastic Agents (Antineoplastics)IBA
03/2023 - 06/2010
5Histone DemethylasesIBA
01/2022 - 01/2017
5Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 11/2013
4Proteolysis Targeting ChimeraIBA
10/2023 - 10/2020
4snake venom protein C activatorIBA
10/2023 - 10/2020
4Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2022 - 02/2020
4indoleIBA
01/2021 - 12/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
07/2019 - 07/2013
4Chalcone (Benzalacetophenone)IBA
01/2017 - 03/2015
3Transcription Factors (Transcription Factor)IBA
02/2024 - 01/2021
3TriazolesIBA
03/2023 - 11/2013
3B7-H1 AntigenIBA
07/2022 - 02/2020
3DNA (Deoxyribonucleic Acid)IBA
06/2022 - 01/2018
3ThiosemicarbazonesIBA
01/2021 - 12/2017
3Adenosine Triphosphate (ATP)IBA
01/2021 - 11/2019
3NucleosidesIBA
11/2014 - 10/2008
2Ligases (Synthetase)IBA
11/2023 - 01/2021
2AcridinesIBA
11/2023 - 05/2023
2Phosphotransferases (Kinase)IBA
03/2023 - 01/2023
2phenothiazineIBA
01/2023 - 11/2017
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2022 - 03/2021
2Programmed Cell Death 1 ReceptorIBA
07/2022 - 03/2021
2ChromatinIBA
06/2022 - 01/2021
2jaridon 6IBA
10/2021 - 11/2017
2CytokinesIBA
07/2021 - 07/2019
2Deubiquitinating EnzymesIBA
04/2021 - 04/2020
2ubiquitin-Nalpha-protein hydrolaseIBA
03/2021 - 04/2020
2GSK2879552IBA
01/2021 - 01/2017
2Alkynes (Acetylenes)IBA
01/2021 - 02/2015
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021 - 11/2019
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 07/2018
2AmidesIBA
10/2020 - 04/2020
2TubulinIBA
10/2020 - 10/2017
2Amino AcidsFDA Link
11/2019 - 11/2019
2Matrix Metalloproteinases (MMPs)IBA
04/2019 - 12/2013
2PiperazineIBA
05/2018 - 01/2018
2HydrazonesIBA
03/2018 - 11/2016
2ThioureaIBA
10/2017 - 02/2015
2geridoninIBA
02/2017 - 11/2016
2Sirolimus (Rapamycin)FDA Link
01/2017 - 01/2016
22- (3- (4- ((2,6- dimethylmorpholino)methyl)styryl)- 1H- indazol- 6- yl)- 5'- methoxyspiro(cyclopropane- 1,3'- indolin)- 2'- oneIBA
01/2016 - 01/2015
2OxindolesIBA
06/2015 - 05/2014
2jaridoninIBA
01/2015 - 07/2013
2Tumor Biomarkers (Tumor Markers)IBA
11/2014 - 10/2008
2andrographolideIBA
12/2013 - 12/2011
2Sildenafil Citrate (Viagra)FDA Link
03/2012 - 12/2010
1Immunoglobulins (Immunoglobulin)IBA
03/2024
1Cysteine Proteases (Cysteine Protease)IBA
02/2024
1UbiquitinIBA
02/2024
1Micafungin (FK463)FDA Link
11/2023
1Interleukin-1 Receptor-Associated KinasesIBA
10/2023
1Amsacrine (AMSA)IBA
05/2023
1LigandsIBA
05/2023
1Tranylcypromine (Parnate)FDA LinkGeneric
05/2023
1Linezolid (Zyvox)FDA Link
03/2023
1Oxazolidinones (2 Oxazolidone)IBA
03/2023
1tedizolid phosphateIBA
03/2023
1contezolidIBA
03/2023
1PyrimidinesIBA
03/2023
1Histone Deacetylase InhibitorsIBA
03/2023
1Tocopherols (Tocopherol)IBA
03/2023

Therapy/Procedure

42Therapeutics
01/2024 - 12/2010
9Drug Therapy (Chemotherapy)
01/2023 - 01/2018
8Immunotherapy
03/2024 - 01/2021
3Oral Administration
10/2017 - 02/2015